000 01741 a2200493 4500
005 20250514193837.0
264 0 _c20040909
008 200409s 0 0 eng d
022 _a0008-5472
024 7 _a10.1158/0008-5472.CAN-03-3025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRadhakrishnan, Suresh
245 0 0 _aImmunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity.
_h[electronic resource]
260 _bCancer research
_cJul 2004
300 _a4965-72 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
650 0 4 _aAnimals
650 0 4 _aAntibody Specificity
650 0 4 _aB7-1 Antigen
_ximmunology
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aGranzymes
650 0 4 _aImmunization, Passive
_xmethods
650 0 4 _aImmunoglobulin M
_ximmunology
650 0 4 _aLung Neoplasms
_ximmunology
650 0 4 _aMelanoma, Experimental
_ximmunology
650 0 4 _aMembrane Glycoproteins
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aPerforin
650 0 4 _aPore Forming Cytotoxic Proteins
650 0 4 _aProgrammed Cell Death 1 Ligand 2 Protein
650 0 4 _aReceptors, IgG
650 0 4 _aSerine Endopeptidases
_ximmunology
700 1 _aNguyen, Loc Tan
700 1 _aCiric, Bogoljub
700 1 _aFlies, Dallas
700 1 _aVan Keulen, Virginia P
700 1 _aTamada, Koji
700 1 _aChen, Lieping
700 1 _aRodriguez, Moses
700 1 _aPease, Larry R
773 0 _tCancer research
_gvol. 64
_gno. 14
_gp. 4965-72
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-03-3025
_zAvailable from publisher's website
999 _c14959136
_d14959136